Teneligliptin hydrobromide
Teneligliptin hydrobromide is a potent and long-acting DPP-4 inhibitor, demonstrating competitive inhibition with IC50 values around 1 nM in various in vitro assays. This research compound is widely used in studies of type 2 diabetes, enabling investigations into glucose metabolism and insulin secretion in both cellular and animal models.
Product Specifications
CAS Number
906093-29-6
Product Name Alternative
Teneligliptin, FAP, MP513, MP-513, MP-513 (hydrobromide), MP 513, DPP-8, DPP-9, DPP, DPP4, Dipeptidyl peptidase-4, Dipeptidyl Peptidase
Field of Research
Cell Biology, Epigenetics & Chromatin, Immunology & Inflammation, Pharmacology & Drug Discovery, Protein Biochemistry, Signal Transduction
Purity
97.83% (May vary between batches)
Solubility
DMSO:50 mg/mL (79.51 mM) ; H2O:100 mg/mL (159.02 mM) ; Ethanol:17 mg/mL (27.03 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.18 mM)
Smiles
Br.Br.Br.Br.Br.Cc1cc (N2CCN (CC2) C2CNC (C2) C (=O) N2CCSC2) n (n1) -c1ccccc1.Cc1cc (N2CCN (CC2) C2CNC (C2) C (=O) N2CCSC2) n (n1) -c1ccccc1
Molecular Formula
C22H30N6OS·5/2BrH
Molecular Weight
628.86
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
C4B (Complement C4-B, Basic Complement C4, C3 and PZP-like alpha-2-macroglobulin Domain-containing Protein 3, CO4, CPAMD3)
